Promise and pitfalls of the Immunochip
Arthritis Research & Therapy2010Vol. 13(1), pp. 101–101
Citations Over TimeTop 1% of 2010 papers
Abstract
Genomewide association studies (GWAS) have proven a powerful hypothesis-free method to identify common disease-associated variants. Even quite large GWAS, however, have only at best identified moderate proportions of the genetic variants contributing to disease heritability. To provide cost-effective genotyping of common and rare variants to map the remaining heritability and to fine-map established loci, the Immunochip Consortium has developed a 200,000 SNP chip that has been produced in very large numbers for a fraction of the cost of GWAS chips. This chip provides a powerful tool for immunogenetics gene mapping.
Related Papers
- → The mystery of missing heritability: Genetic interactions create phantom heritability(2012)1,607 cited
- → Elements of ‘missing heritability’(2012)68 cited
- → Why the missing heritability might not be in the DNA(2017)53 cited
- → Quantitative Genetics: Heritability Is Not Always Missing(2013)11 cited
- → Inferring the nature of missing heritability in human traits(2018)1 cited